Oxidation of Helix-3 Methionines Precedes the Formation of PK Resistant PrP
While elucidating the peculiar epitope of the α-PrP mAb IPC2, we found that PrPSc exhibits the sulfoxidation of residue M213 as a covalent signature. Subsequent computational analysis predicted that the presence of sulfoxide groups at both Met residues 206 and 213 destabilize the α-fold, suggesting oxidation may facilitate the conversion of PrPC into PrPSc. To further study the effect of oxidation on prion formation, we generated pAbs to linear PrP peptides encompassing the Helix-3 region, as opposed to the non-linear complexed epitope of IPC2. We now show that pAbs, whose epitopes comprise Met residues, readily detected PrPC, but could not recognize most PrPSc bands unless they were vigorously reduced. Next, we showed that the α-Met pAbs did not recognize newly formed PrPSc, as is the case for the PK resistant PrP present in lines of prion infected cells. In addition, these reagents did not detect intermediate forms such as PK sensitive and partially aggregated PrPs present in infected brains. Finally, we show that PrP molecules harboring the pathogenic mutation E200K, which is linked to the most common form of familial CJD, may be spontaneously oxidized. We conclude that the oxidation of methionine residues in Helix-3 represents an early and important event in the conversion of PrPC to PrPSc. We believe that further investigation into the mechanism and role of PrP oxidation will be central in finally elucidating the mechanism by which a normal cell protein converts into a pathogenic entity that causes fatal brain degeneration.
Vyšlo v časopise:
Oxidation of Helix-3 Methionines Precedes the Formation of PK Resistant PrP. PLoS Pathog 6(7): e32767. doi:10.1371/journal.ppat.1000977
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.ppat.1000977
Souhrn
While elucidating the peculiar epitope of the α-PrP mAb IPC2, we found that PrPSc exhibits the sulfoxidation of residue M213 as a covalent signature. Subsequent computational analysis predicted that the presence of sulfoxide groups at both Met residues 206 and 213 destabilize the α-fold, suggesting oxidation may facilitate the conversion of PrPC into PrPSc. To further study the effect of oxidation on prion formation, we generated pAbs to linear PrP peptides encompassing the Helix-3 region, as opposed to the non-linear complexed epitope of IPC2. We now show that pAbs, whose epitopes comprise Met residues, readily detected PrPC, but could not recognize most PrPSc bands unless they were vigorously reduced. Next, we showed that the α-Met pAbs did not recognize newly formed PrPSc, as is the case for the PK resistant PrP present in lines of prion infected cells. In addition, these reagents did not detect intermediate forms such as PK sensitive and partially aggregated PrPs present in infected brains. Finally, we show that PrP molecules harboring the pathogenic mutation E200K, which is linked to the most common form of familial CJD, may be spontaneously oxidized. We conclude that the oxidation of methionine residues in Helix-3 represents an early and important event in the conversion of PrPC to PrPSc. We believe that further investigation into the mechanism and role of PrP oxidation will be central in finally elucidating the mechanism by which a normal cell protein converts into a pathogenic entity that causes fatal brain degeneration.
Zdroje
1. PrusinerSB
ScottMR
DeArmondSJ
CohenFE
1998 Prion protein biology. Cell 93(3) 337 348
2. BrownDR
2005 Neurodegeneration and oxidative stress: prion disease results from loss of antioxidant defence. Folia Neuropathol 43 229 243
3. NadalRC
AbdelraheimSR
BrazierMW
RigbySE
BrownDR
2007 Prion protein does not redox-silence Cu2+, but is a sacrificial quencher of hydroxyl radicals. Free Radic Biol Med 42 79 89
4. BrownDR
CliveC
HaswellSJ
2001 Antioxidant activity related to copper binding of native prion protein. J Neurochem 76 69 76
5. BrownDR
SassoonJ
2002 Copper-dependent functions for the prion protein. Mol Biotechnol 22 165 178
6. PanKM
BaldwinM
NguyenJ
GassetM
SerbanA
1993 Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. Proc Natl Acad Sci U S A 90(23) 10962 10966
7. CanelloT
EngelsteinR
MoshelO
XanthopoulosK
JuanesME
2008 Methionine sulfoxides on PrPSc: a prion-specific covalent signature. Biochemistry 47 8866 8873
8. OienDB
CanelloT
GabizonR
GassetM
LundquistBL
2009 Detection of oxidized methionine in selected proteins, cellular extracts and blood serums by novel anti-methionine sulfoxide antibodies. Arch Biochem Biophys 485 35 40
9. StahlN
BaldwinMA
TeplowDB
HoodL
GibsonBW
1993 Structural studies of the scrapie prion protein using mass spectrometry and amino acid sequencing. Biochemistry 32 1991 2002
10. RequenaJR
GrothD
LegnameG
StadtmanER
PrusinerSB
2001 Copper-catalyzed oxidation of the recombinant SHa(29-231) prion protein. Proc Natl Acad Sci U S A 98 7170 7175
11. HirschbergerT
StorkM
SchroppB
WinklhoferKF
TatzeltJ
2006 Structural instability of the prion protein upon M205S/R mutations revealed by molecular dynamics simulations. Biophys J 90 3908 3918
12. MoskovitzJ
Bar-NoyS
WilliamsWM
RequenaJ
BerlettBS
2001 Methionine sulfoxide reductase (MsrA) is a regulator of antioxidant defense and lifespan in mammals. Proc Natl Acad Sci U S A 98 12920 12925
13. BingerKJ
GriffinMD
HeinemannSH
HowlettGJ
Methionine-oxidized amyloid fibrils are poor substrates for human methionine sulfoxide reductases A and B2. Biochemistry 49 2981 2983
14. TamguneyG
GilesK
GliddenDV
LessardP
WilleH
2008 Genes contributing to prion pathogenesis. J Gen Virol 89 1777 1788
15. ColomboG
MeliM
MorraG
GabizonR
GassetM
2009 Methionine sulfoxides on prion protein Helix-3 switch on the alpha-fold destabilization required for conversion. PLoS ONE 4 e4296
16. WolschnerC
GieseA
KretzschmarHA
HuberR
MoroderL
2009 Design of anti- and pro-aggregation variants to assess the effects of methionine oxidation in human prion protein. Proc Natl Acad Sci U S A 106 7756 7761
17. LisaS
MeliM
CabelloG
GabizonR
ColomboG
2010 The structural intolerance of the.PrP a-fold for polar substitution of the helix-3 methionines. Cell Mol Life Sci in press
18. HsiaoK
MeinerZ
KahanaE
CassC
KahanaI
1991 Mutation of the prion protein in Libyan Jews with Creutzfeldt-Jakob disease. N Engl J Med 324 1091 1097
19. WeiskopfD
SchwanningerA
WeinbergerB
AlmanzarG
ParsonW
2010 Oxidative stress can alter the antigenicity of immunodominant peptides. J Leukoc Biol 87 165 172
20. SulzerB
PerelsonAS
1997 Immunons revisited: binding of multivalent antigens to B cells. Mol Immunol 34 63 74
21. WilliamsonRA
PeretzD
PinillaC
BallH
BastidasRB
1998 Mapping the prion protein using recombinant antibodies. J Virol 72 9413 9418
22. HoughtenRA
LiCH
1979 Reduction of sulfoxides in peptides and proteins. Anal Biochem 98 36 46
23. ButlerDA
ScottMR
BockmanJM
BorcheltDR
TaraboulosA
1988 Scrapie-infected murine neuroblastoma cells produce protease-resistant prion proteins. J Virol 62 1558 1564
24. LeuchtC
SimoneauS
ReyC
VanaK
RiegerR
2003 The 37 kDa/67 kDa laminin receptor is required for PrP(Sc) propagation in scrapie-infected neuronal cells. EMBO Rep 4 290 295
25. LiuY
SunR
ChakrabartyT
ManuelidisL
2008 A rapid accurate culture assay for infectivity in Transmissible Encephalopathies. J Neurovirol 14 352 361
26. ScottMR
KohlerR
FosterD
PrusinerSB
1992 Chimeric prion protein expression in cultured cells and transgenic mice. Protein Sci 1 986 997
27. CaspiS
HalimiM
YanaiA
SassonSB
TaraboulosA
1998 The anti-prion activity of Congo red. Putative mechanism. J Biol Chem 273 3484 3489
28. BorcheltDR
ScottM
TaraboulosA
StahlN
PrusinerSB
1990 Scrapie and cellular prion proteins differ in their kinetics of synthesis and topology in cultured cells. J Cell Biol 110 743 752
29. CaugheyB
RaceRE
ErnstD
BuchmeierMJ
ChesebroB
1989 Prion protein biosynthesis in scrapie-infected and uninfected neuroblastoma cells. J Virol 63 175 181
30. TzabanS
FriedlanderG
SchonbergerO
HoronchikL
YedidiaY
2002 Protease-sensitive scrapie prion protein in aggregates of heterogeneous sizes. Biochemistry 41 12868 12875
31. SafarJ
CeroniM
PiccardoP
LiberskiPP
MiyazakiM
1990 Subcellular distribution and physicochemical properties of scrapie-associated precursor protein and relationship with scrapie agent. Neurology 40 503 508
32. SafarJ
WilleH
ItriV
GrothD
SerbanH
1998 Eight prion strains have PrP(Sc) molecules with different conformations. Nat Med 4 1157 1165
33. SerbanD
TaraboulosA
DeArmondSJ
PrusinerSB
1990 Rapid detection of Creutzfeldt-Jakob disease and scrapie prion proteins. Neurology 40 110 117
34. GabizonR
TellingG
MeinerZ
HalimiM
KahanaI
1996 Insoluble wild-type and protease-resistant mutant prion protein in brains of patients with inherited prion disease. Nat Med 2 59 64
35. ChenSG
ParchiP
BrownP
CapellariS
ZouW
1997 Allelic origin of the abnormal prion protein isoform in familial prion diseases. Nat Med 3 1009 1015
36. SwietnickiW
PetersenRB
GambettiP
SurewiczWK
1998 Familial mutations and the thermodynamic stability of the recombinant human prion protein. J Biol Chem 273 31048 31052
37. ZhangY
SwietnickiW
ZagorskiMG
SurewiczWK
SonnichsenFD
2000 Solution structure of the E200K variant of human prion protein. Implications for the mechanism of pathogenesis in familial prion diseases. J Biol Chem 275 33650 33654
38. WinklhoferKF
HeskeJ
HellerU
ReintjesA
MuranyiW
2003 Determinants of the in vivo folding of the prion protein. A bipartite function of helix 1 in folding and aggregation. J Biol Chem 278 14961 14970
39. HartT
HosszuLL
TrevittCR
JacksonGS
WalthoJP
2009 Folding kinetics of the human prion protein probed by temperature jump. Proc Natl Acad Sci U S A 106 5651 5656
40. SilvaCJ
OniskoBC
DyninI
EricksonML
VenselWH
Assessing the role of oxidized methionine at position 213 in the formation of prions in hamsters. Biochemistry 49 1854 1861
41. FroelichJM
ReidGE
2008 The origin and control of ex vivo oxidative peptide modifications prior to mass spectrometry analysis. Proteomics 8 1334 1345
42. OniskoB
DyninI
RequenaJR
SilvaCJ
EricksonM
2007 Mass spectrometric detection of attomole amounts of the prion protein by nanoLC/MS/MS. J Am Soc Mass Spectrom 18 1070 1079
43. SpudichS
MastrianniJA
WrenschM
GabizonR
MeinerZ
1995 Complete penetrance of Creutzfeldt-Jakob disease in Libyan Jews carrying the E200K mutation in the prion protein gene. Mol Med 1 607 613
44. ChapmanJ
Ben-IsraelJ
GoldhammerY
KorczynAD
1994 The risk of developing Creutzfeldt-Jakob disease in subjects with the PRNP gene codon 200 point mutation. Neurology 44 1683 1686
45. StadtmanER
BerlettBS
1997 Reactive oxygen-mediated protein oxidation in aging and disease. Chem Res Toxicol 10 485 494
46. MakaravaN
KovacsGG
BocharovaO
SavtchenkoR
AlexeevaI
2010 Recombinant prion protein induces a new transmissible prion disease in wild-type animals. Acta Neuropathol 119 177 187
47. LegnameG
BaskakovIV
NguyenHO
RiesnerD
CohenFE
2004 Synthetic mammalian prions. Science 305 673 676
48. SaborioGP
PermanneB
SotoC
2001 Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature 411 810 813
49. AtarashiR
MooreRA
SimVL
HughsonAG
DorwardDW
2007 Ultrasensitive detection of scrapie prion protein using seeded conversion of recombinant prion protein. Nat Methods 4 645 650
50. WangF
WangX
YuanCG
MaJ
Generating a prion with bacterially expressed recombinant prion protein. Science 327 1132 1135
51. BuelerH
FischerM
LangY
BluethmannH
LippHP
1992 Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein [see comments]. Nature 356 577 582
52. VaradarajanS
YatinS
AksenovaM
ButterfieldDA
2000 Review: Alzheimer's amyloid beta-peptide-associated free radical oxidative stress and neurotoxicity. J Struct Biol 130 184 208
53. ChiL
KeY
LuoC
GozalD
LiuR
2007 Depletion of reduced glutathione enhances motor neuron degeneration in vitro and in vivo. Neuroscience 144 991 1003
54. Gonzalez-IglesiasR
PajaresMA
OcalC
EspinosaJC
OeschB
2002 Prion protein interaction with glycosaminoglycan occurs with the formation of oligomeric complexes stabilized by Cu(II) bridges. J Mol Biol 319 527 540
55. MakaravaN
BaskakovIV
2008 Expression and purification of full-length recombinant PrP of high purity. Methods Mol Biol 459 131 143
Štítky
Hygiena a epidemiológia Infekčné lekárstvo LaboratóriumČlánok vyšiel v časopise
PLOS Pathogens
2010 Číslo 7
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Koronavirus hýbe světem: Víte jak se chránit a jak postupovat v případě podezření?
Najčítanejšie v tomto čísle
- RNA Virus Replication Complexes
- Virus-Infection or 5′ppp-RNA Activates Antiviral Signal through Redistribution of IPS-1 Mediated by MFN1
- Functional Genetic Diversity among Complex Clinical Isolates: Delineation of Conserved Core and Lineage-Specific Transcriptomes during Intracellular Survival
- Extreme CD8 T Cell Requirements for Anti-Malarial Liver-Stage Immunity following Immunization with Radiation Attenuated Sporozoites